23/12/2008
AstraZeneca links up with Biocompatibles for GLP-1 drug
AstraZeneca has signed an agreement to develop a diabetes drug with the UK’s Biocompatibles which could change the face of the Farnham, Surrey-based firm, which is best known for its devices
23/12/2008
Ranbaxy to pay £1 million to settle Scottish “cartel” case
Ranbaxy will pay compensation of £1,057,500 to Scotland’s government and health boards to settle allegations that it engaged in anti-competitive conduct in connection with the supply of drugs to the NHS
22/12/2008
NHS to be £13 million off budget by 2013 - Monitor's forecast
The executive chair of NHS foundation trust regulator Monitor has warned that the health service faces a £13 billion annual shortfall by 2013
23/12/2008
Antisoma looks for partner for US-approved oral fludarabine
Antisoma of the UK is celebrating the news that the US Food and Drug Administration has approved its tablet formulation of fludarabine as a second-line treatment for chronic lymphocytic leukaemia
23/12/2008
MHRA consults on proposals to battle counterfeit drugs
The MHRA says it wants to hear from “everyone” who is likely to be affected by its newly-announced proposals to strengthen the UK medicines supply chain in light of the growing threat of counterfeit medicines
22/12/2008
SkyePharma halts plan to sell formoterol Certihaler in USA
SkyePharma has suffered a setback as the UK drug delivery firm revealed that discussions concerning the commercialisation in the USA of its asthma treatment formoterol Certihaler have ended